COVID-19 viral rebound infections continue to impact patients and challenge clinicians. To help us better understand why some patients experience it—and how antiviral medication plays a role—Dr. Charles Turck and Dr. Jonathan Li explore COVID-19 rebound infections and antiviral treatment nirmatrelvir/ritonavir.